Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations

Purpose: The relationship between plasma concentration and antitumor activity of gefitinib was assessed in patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. Patients and methods: Plasma trough levels of gefitinib were measured on days 2 (D2) and 8 (D8) by high-performance liquid chromatography in 31 patients. Plasma concentrations of gefitinib were also measured 10 h after the first administration in 21 of these patients to calculate the elimination half-life of gefitinib. Results: The median trough levels were: 197 ng/ml 10 h from the first administration of gefitinib; 113 ng/ml on D2; and 358 ng/ml on D8. The median D8/D2 ratio was 2.709, and the median elimination half-life was 15.7 h. The median progression-free survival (PFS) was 273 days, and the median overall survival (OS) was 933 days. A high D8/D2 ratio was significantly correlated with better PFS, though the plasma trough levels on D2 and D8 were not significantly related to PFS. The elimination half-life was not a significant factor for PFS, but it was significantly correlated with high-grade adverse events. Pharmacokinetic parameters were not significantly correlated with OS. Conclusions: A high D8/D2 ratio, but not elimination half-life, might be a predictor of better PFS in patients with NSCLC harboring EGFR mutations treated with gefitinib. On the other hand, long elimination half-life was related to high-grade adverse events in these patients.;開始ページ : 377;終了ページ : 382;元資料の権利情報 : © Springer-Verlag Berlin Heidelberg 2016;元資料の権利情報 : The final publication is available at link.springer.com

「国立国会図書館デジタルコレクション(雑誌)」より

この本の情報

書名 Pharmacokinetic parameters of gefitinib predict efficacy
and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations
著作者等 溝口 孝輔
書名別名 ゲフィチニブの薬物動態パラメーターと無増悪生存期間・有害事象との相関
出版元 Springer
ISSN 03445704
NCID AA00598397
※クリックでCiNii Booksを表示
言語 英語
出版国 ドイツ
この本を: 
このエントリーをはてなブックマークに追加

Yahoo!ブックマークに登録
この記事をクリップ!
Clip to Evernote
このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想